Polymorphisms in human soluble epoxide hydrolase

Molecular Pharmacology

Volumn 64, Issue 2, 2003, Pages 482-490

  Przybyla Zawislak, Beata D ^a   Srivastava, Punit K ^b   Vázquez Matías, Johana ^c   Mohrenweiser, Harvey W ^c   Maxwell, Joseph E ^d   Hammock, Bruce D ^d   Bradbury, J Alyce ^e   Enayetallah, Ahmed E ^b   Zeldin, Darryl C ^e   Grant, David F ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; AMINO ACID; ARACHIDONIC ACID; ARGININE; COMPLEMENTARY DNA; CYSTEINE; EPOXIDE; EPOXIDE HYDROLASE; GLYCINE; LINOLEIC ACID; TRANS STILBENE OXIDE; TYROSINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; EXON; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ANIMALS; BACULOVIRIDAE; CRYSTALLIZATION; ENZYME STABILITY; EPOXIDE HYDROLASES; EXONS; GENETIC VECTORS; GENOTYPE; HUMANS; KINETICS; MICE; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; SOLUBILITY; TUMOR CELLS, CULTURED;

EID: 0042343719     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.2.482     Document Type: Article

References (36)

1. Argiriadi MA, Morisseau C, Goodrow MH, Dowdy DL, Hammock BD, and Christianson DW (2000) Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation. J Biol Chem 275:15265-15270.
2. Argiriadi MA, Morisseau C, Hammock BD, and Christianson DW (1999) Detoxification of environmental mutagens and carcinogens; structure, mechanism, and evolution of liver epoxide hydrolase. Proc Natl Acad Sci USA 96:10637-10642.
3. Beetham JK, Grant D, Arand M, Garbarino J, Kiyosue T, Pinot F, Oesch F, Belknap WR, Shinozaki K, and Hammock BD (1995) Gene evolution of epoxide hydrolases and recommended nomenclature. DNA Cell Biol 14:61-71.
4. Beetham JK, Tian T, and Hammock BD (1993) cDNA cloning and expression of a soluble epoxide hydrolase from human liver. Arch Biochem Biophys 305:197-201.
5. Borhan B, Mebrahtu T, Nazarian S, Kurth MJ, and Hammock BD (1995) Improved radiolabeled substrates for soluble epoxide hydrolase. Anal Biochem 231:188-200.
6. Catella F, Lawson JA, Fitzgerald DJ, and FitzGerald GA (1990) Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci USA 87:5893-5897.
7. Dietze EC, Magdalou J, and Hammock BD (1990) Human and murine cytosolic epoxide hydrolase: physical and structural properties. Int J Biochem 22:461-470.
8. Gill SS (1983) Purification of mouse liver cytosolic epoxide hydrolase. Biochem Biophys Res Commun 112:763-769.
9. Larsson C, White I, Johansson C, Stark A, and Meijer J (1995) Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21-p12. Hum Genet 95:356-358.
10. Liu JQ, Kurihara T, Miyagi M, Esaki N, and Soda K (1995) Reaction mechanism of L-2-haloacid dehalogenase of Pseudomonas sp. YL. Identification of Asp10 as the active site nucleophile by 180 incorporation experiments. J Biol Chem 270:18309-18312.
11. Mertes I, Fleischmann R, Glatt HR, and Oesch F (1985) Interindividual variations in the activities of cytosolic and microsomal episode hydrolase in human liver. Carcinogenesis 6:219-223.
12. Nickerson DA, Tobe VO, and Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25:2745-2751.
13. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, and Liao JK (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science (Wash DC) 285:1276-1279.
14. Norris KK, DeAngelo TM, and Vesell ES (1989) Genetic and environmental factors that regulate cytosolic epoxide hydrolase activity in normal human lymphocytes. J Clin Invest 84:1749-1756.
15. O'Reilly DR, Miller LK and Luckow VA. Baculovirus Expression Vectors: A Laboratory Manual. Freeman and Company, New York (1992).
16. Pacifici GM, Temellini A, Giuliani L, Rane A, Thomas H, and Oesch F (1988) Cytosolic epoxide hydrolase in humans: development and tissue distribution. Arch Toxicol 62:254-257.
17. Pascual JM, McKenzie A, Yankaskas JR, Falck JR, and Zeldin DC (1998) Epoxygenase metabolites of arachidonic acid affect electrophysiologic properties of rat tracheal epithelial cells1. J Pharmacol Exp Ther 286:772-779.
18. Pinot F, Grant DF, Beetham JK, Parker AG, Borhan B, Landt S, Jones AD, and Hammock BD (1995a) Molecular and biochemical evidence for the involvement of the Asp-333-His-523 pair in the catalytic mechanism of soluble epoxide hydrolase. J Biol Chem 270:7968-7974.
19. Pinot F, Grant DF, Spearow JL, Parker AG, and Hammock BD (1995b) Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. Biochem Pharm 50:501-508.
20. Rahman M, Wright JT Jr, and Douglas JG (1997) The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review. Am J Hypertens 10:356-365.
21. Rywik SL, Williams OD, Pajak A, Broda G, Davis CE, Kawalec E, Manolio TA, Piotrowski W and Hutchinson R (2000) Incidence and correlates of hypertension in the Atherosclerosis Risk in Communities (ARIC) study and the Monitoring Trends and Determinants of Cardiovascular Disease (POL-MONICA) project. J Hypertens 18:999-1006.
22. Sambrook J, Fritsch EF and Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview, New York (1989).
23. Sandberg M, Hassett C, Adman ET, Meijer J, and Omiecinski CJ (2000) Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 275:28873-28881.
24. Sandberg M and Meijer J (1996) Structural characterization of the human soluble epoxide hydrolase gene (EPHX2). Biochem Biophys Res Commun 221:333-339.
25. Segel IH (1975) Enzyme Kinetics. Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. John Wiley and Sons, New York.
26. Shen MR, Jones IM, and Mohrenweiser H (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604-608.
27. Sherry ST, Ward M, and Sirotkin K (2000) Use of molecular variation in the NCBI dbSNP database. Hum Mutat 15:68-75.
28. Silva MH and Hammock BD (1987) Affinity purification of cytosolic epoxide hydrolase from human, rhesus monkey, baboon, rabbit, rat and mouse liver. Comp Biochem Physiol B 87:95-102.
29. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, and Gonzalez FJ (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275:40504-40510.
30. Su P, Kaushal KM and Kroetz DL (1998) Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Am J Physiol 275:R426-R438.
31. Verschueren KH, Seljee F, Rozeboom HJ, Kalk KH, and Dijkstra BW (1993) Crystallographic analysis of the catalytic mechanism of haloalkane dehalogenase. Nature (Lond) 363:693-698.
32. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, et al. (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science (Wash DC) 280:1077-1082.
33. Wixtrom RN and Hammock BD (1985) Membrane-bound and soluble-fraction epoxide hydrolases; Methodological aspects, in Methodological aspects of drug metabolizing enzymes (Zakim D, Vessey DA eds) pp 1-93, John Wiley & Sons, Inc., New York.
34. Wu S, Chen W, Murphy E, Gabel S, Tomer KB, Foley J, Steenbergen C, Falck JR, Moomaw CR, and Zeldin DC (1997) Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272:12551-12559.
35. Zeldin DC, Kobayashi J, Falck JR, Winder BS, Hammock BD, Snapper JR, and Capdevila JH (1993) Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem 268:6402-6407.
36. Zeldin DC, Wei S, Falck JR, Hammock BD, Snapper JR, and Capdevila JH (1995) Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch Biochem Biophys 316:443-451.